Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-α antagonists

Muscle and Nerve

Volumn 41, Issue 5, 2010, Pages 723-727

  Alshekhlee, Amer ^a   Basiri, Kevian ^a,b   Miles, J Douglas ^a,c   Ahmad, Saef A ^a   Katirji, Bashar ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MARSHALL UNIVERSITY   (United States)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Electrodiagnosis; Etanercept; Infliximab; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; PREDNISONE; SERUM ALBUMIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ALBUMIN BLOOD LEVEL; AREFLEXIA; ARTHRALGIA; ARTICLE; ATAXIA; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DEMYELINATION; DISEASE COURSE; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAND PARESTHESIA; HUMAN; IMMOBILIZATION; IMMUNOTHERAPY; JOINT SWELLING; LIMB SWELLING; MALE; MORNING STIFFNESS; MOTOR NEUROPATHY; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; PAIN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; RHEUMATOID ARTHRITIS; SENSORY DYSFUNCTION; SENSORY NEUROPATHY; UNSTEADINESS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ELECTRODIAGNOSIS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; NEURAL CONDUCTION; PAIN; PARAPARESIS; PERIPHERAL NERVES; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RECEPTORS, TUMOR NECROSIS FACTOR; RECOVERY OF FUNCTION; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951289793     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21584     Document Type: Article

References (25)

1. Stübgen JP. Tumor necrosis factor-alpha antagonists and neuropathy. Muscle Nerve 2008;37:281-292.
2. Hooper DR, Tarnopolsky MA, Baker SK. Lewis-Sumner syndrome associated with infliximab therapy in rheumatoid arthritis. Muscle Nerve 2008;38:1318-1325.
3. Alldred A. Etanercept in rheumatoid arthritis. Expert Opin Pharmacother 2001;1:1137-1148.
4. Bressler B, Law JK, Al Nahdi Sheraisher N, Atkinson K, Byrne MF, Chung HV, et al. The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis. Can J Gastroenterol 2008;22:937-940.
5. Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Efficacy and safety of infliximab monotherapy for plaquetype psoriasis: a randomised trial. Lancet 2001;357:1842-1847. (Pubitemid 32539117)
6. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomized trial. Lancet 2002;359:1541-1549. (Pubitemid 34621118)
7. Maini R, St Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 1999;354:1932-1939.
8. Sieper J, Baraliakos X, Listing J, Brandt J, Haibel H, Rudwaleit M, et al. Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology (Oxford) 2005;44:1525-1530. (Pubitemid 41742469)
9. Fromont A, De Seze J, Fleury MC, Maillefert JF, Moreau T. Inflammatory demyelinating events following treatment with anti-tumor necrosis factor. Cytokine 2009;45:55-57.
10. Lozeron P, Denier C, Lacroix C, Adams D. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol 2009;66:490-497.
11. Cocito D, Bergamasco B, Tavella A, Poglio F, Paolasso I, Costa P, et al. Multifocal motor neuropathy during treatment with infliximab. J Peripher Nerv Syst 2005;10:386-387. (Pubitemid 43920044)
12. Jarand J, Zochodne DW, Martin LO, Voll C. Neurological complications of infliximab. J Rheumatol 2006;33:1018-1020.
13. Paolazzi G, Peccatori S, Cavatorta FP, Morini A. A case of spontaneously recovering multifocal motor neuropathy with conduction blocks (MMNCB) during anti-TNF alpha therapy for ankylosing spondylitis. Clin Rheumatol 2009;28:993-995.
14. Rodriguez-Escalera C, Belzunegui J, Lopez-Dominguez L, Gonzalez C, Figueroa M. Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy. Rheumatology (Oxford) 2005;44:132-133. (Pubitemid 40124349)
15. Singer OC, Otto B, Steinmetz H, Ziemann U. Acute neuropathy with multiple conduction blocks after TNFalpha monoclonal antibody therapy. Neurology 2004;63:1754. (Pubitemid 39507613)
16. Tektonidou MG, Serelis J, Skopouli FN. Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment. Clin Rheumatol 2007;26:258-260. (Pubitemid 46020257)
17. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, et al. Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 2003;30:2287-2291. (Pubitemid 37221866)
18. Richette P, Dieudé P, Damiano J, Lioté F, Orcel P, Bardin T. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol 2004;31:2079-2081. (Pubitemid 39336740)
19. Cisternas M, Gutiérrez M, Jacobelli S. Successful rechallenge with anti-tumor necrosis factor alpha for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment. Arthritis Rheum 2002;46:3107-3108.
20. Richez C, Blanco P, Lagueny A, Schaeverbeke T, Dehais J. Neuropathy resembling CIDP in patients receiving tumor necrosis factor-α blockers. Neurology 2005;64:1468-1470. (Pubitemid 40570527)
21. Nicolas G, Maisonobe T, Le Forestier N, Léger JM, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002;25: 26-30.
22. The French CIDP Study Group. Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 2008;79:115-118.
23. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:617-618.
24. Barohn RJ, Saperstein DS. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Semin Neurol 1998; 18:49-61.
25. Alshekhlee A, Hachwi RN, Preston DC, Katirji B. New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy. Muscle Nerve 2005;32:66-72.